Newfoundland Cancer Treatment & Research Foundation Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2002
NCT00168181
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now